Growth Metrics

Bio-Techne (TECH) FCF Payout Ratio Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.27%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -60.24%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -60.24%
Dec 31, 2025 -0.76%
Sep 30, 2025 141.49%
Jun 30, 2025 -39.53%
Mar 31, 2025 108.25%
Dec 31, 2024 -10.72%
Sep 30, 2024 -16.09%
Jun 30, 2024 26.46%
Mar 31, 2024 -39.92%
Dec 31, 2023 -14.63%
Sep 30, 2023 2.49%
Jun 30, 2023 23.42%
Mar 31, 2023 49.67%
Dec 31, 2022 55.67%
Sep 30, 2022 -8.56%
Jun 30, 2022 25.09%
Mar 31, 2022 11.91%
Dec 31, 2021 -13.04%
Sep 30, 2021 31.65%
Jun 30, 2021 -74.85%
Mar 31, 2021 -36.62%
Dec 31, 2020 -27.08%
Sep 30, 2020 -44.75%
Jun 30, 2020 63.15%
Mar 31, 2020 -12.18%
Dec 31, 2019 -24.19%
Sep 30, 2019 18.47%
Jun 30, 2019 34.42%
Mar 31, 2019 -47.38%
Dec 31, 2018 -21.08%
Sep 30, 2018 12.82%
Jun 30, 2018 -20.34%
Mar 31, 2018 16.28%
Dec 31, 2017 18.54%
Sep 30, 2017 -38.84%
Jun 30, 2017 -27.81%
Mar 31, 2017 63.87%
Dec 31, 2016 -12.95%
Sep 30, 2016 7.21%
Jun 30, 2016 -9.94%
Mar 31, 2016 -24.51%
Dec 31, 2015 -2.86%
Sep 30, 2015 24.25%
Jun 30, 2015 22.93%
Mar 31, 2015 23.24%
Dec 31, 2014 -11.88%
Sep 30, 2014 -3.06%
Jun 30, 2014 -28.60%
Mar 31, 2014 -10.07%
Dec 31, 2013 -13.74%
Sep 30, 2013 -0.38%
Jun 30, 2013 57.79%
Mar 31, 2013 32.11%
Dec 31, 2012 -15.70%
Sep 30, 2012 28.19%
Jun 30, 2012 -5.35%
Mar 31, 2012 -0.42%
Dec 31, 2011 62.99%
Sep 30, 2011 -7.39%
Jun 30, 2011 -5.03%
Mar 31, 2011 -28.98%
Dec 31, 2010 -4.12%
Sep 30, 2010 -4.21%